Taj Pharmaceuticals

Oct 31, 2018

Pharmaceutical Veteran Mr. Shantanu Singh Assumes CFO Taj Pharma as additional charge.

Taj Pharma Inc. (“Taj Pharma” or the “Company”) (TSXV: TPL, an emerging Indian pharmaceutical company, announced today that its board of directors (the “Board”) has accepted the appointment of Mr. Shantanu Kumar Singh New Chief Financial Officer (CFO) of the Company, effective July 26, 2018, as he has decided to take additional opportunities. Shantanu Singh Taj Pharma, Shantanu Singh CFO, Shantanu Singh Director, Pharmaceuticals Veteran, Shantanu Singh News, Shantanu Singh Russia, Shantanu Singh Latest News, Shantanu Singh Latest News, Shantanu Singh Uzbek, Shantanu Singh Mumbai, CFO Shantanu Singh, Shantanu Kumar Singh, Shantanu Singh London, Taj Pharmaceuticals Mumbai, Pharmaceuticals Director, Director Shantanu Singh, Russia Shantanu Singh, Taj CFO Shantanu Singh, Pharma News Shantanu Singh

Mr. Shantanu Kumar Singh — Taj Pharmaceuticals Ltd.

Mr. Shantanu Kumar(Shan) Singh has been appointed by the Board as the new CFO, effective August 1, 2018. Mr. Shantanu Singh is currently the Executive Director of Inovm pharma Inc. and most recently was the CEO of xenon-nanodrugs GmbH, based in Munich, Germany. Prior to that he was the Executive Director of Taj Pharmaceuticals, and has over 10 years business experience that includes senior leadership roles at Taj Ago, Taj Api, Morgan Stanley and Deutsche Bank.

Mr. Abhishek Singh, CEO of Taj Pharma said, “The Board is very thankful to Mr. Ahluwalia for his exemplary service to the Company and wishes him much success in his future endeavors. On behalf of the Board I would also like to welcome Mr.Shantanu Singh to the team and we look forward to working with him as he brings his extensive experience and knowledge to the Company.”

Taj Pharma also announced today that it has authorized the grant of an aggregate of 400,000 stock options (each an “Option”) to certain directors and officers of the Company and its subsidiaries in accordance with the Company’s stock option plan. Each Option will be exercisable into one common share of the Company at the closing market price of the Company’s common shares on the date of grant, for a period of five years from the date of grant. The issuance of the Options is subject to the approval of the TSX Venture Exchange.

About Taj Pharma

Taj Pharma is an emerging Indian pharmaceutical company focused on the development and commercialization of effective and affordable cancer therapeutics in the Russia and North American markets. The Company has recently acquired two generic drugs marketed in the United Kingdom, Capecitabine and Temozolomide. Furthermore, Taj Pharma has filed for marketing approval in selected countries of the EU and with the United States FDA for two additional high value generic oncology drugs and is currently evaluating other products, in different stages of development. Taj Pharma is committed to providing patients with affordable prescription medicines that lower healthcare costs and provide a better quality of life.

Shantanu Singh Taj Pharmaceuticals | Taj Pharmaceuticals Shantanu Singh Breaking News | Taj Pharmaceuticals Latest News | Shantanu Singh | Taj Pharmaceuticals Photos | Taj Pharmaceuticals Videos | Articles on Taj Pharmaceuticals | Shantanu Kumar Singh | Taj Pharmaceuticals India. | Executive Director | Taj Pharma |

Taj Pharmaceuticals, Taj Pharmaceutical Company, Taj Pharmaceuticals, Taj Pharmaceuticals India, Taj Pharmaceuticals Limited, Priyanka Singh Taj Pharma, Abhishek Singh Taj Pharma, Taj Pharmaceuticals Mumbai, Abhishek Kumar Singh Taj Pharma, Priyanka Singh Director Taj Pharma Group, Dr Ranvir Singh Taj Pharma, Dr.Ranvir Singh chairman Taj Pharmaceuticals, Shantanu Singh Director Taj Pharmaceuticals, Abhishek Singh Taj Pharma Mumbai, Priyanka Singh Taj Pharma, Taj Generics Medicines, India’s fastest rising women, Director Taj Pharma, Starting up Priyanka Singh, Taj Pharmaceuticals Bombay, Taj Pharmaceuticals products, Priyanka Singh Taj, Priyanka Singh Taj Agro, Priyanka Singh Director Taj Pharma, Directors of Taj Pharma, Taj Pharmaceuticals News, Taj Pharma News Special Reports, Mumbai-based Taj Pharmaceuticals Limited, Taj Pharma, Taj Pharmaceuticals Limited, Taj Pharma Mumbai, Taj Pharmaceuticals Mumbai, Taj Pharma News Reports, Mumbai-based Taj Pharmaceuticals, Promoters of Taj Pharmaceuticals Limited, Taj Pharmaceuticals Directors, taj pharmaceuticals ceo

Set up in 2004, Taj Pharmaceuticals Ltd. has increased monstrous ability in providing and exchanging Pharmaceutical intermediates, pharmaceutical items, and mass medication and so on. The provider organization is situated in Mumbai, Maharashtra and is one of the main vendors of recorded items. Purchase Pharmaceutical intermediates, pharmaceutical items, and mass medication in mass from us for the best quality items and administration.

We make different sorts of medications that incorporates: Diabetic consideration items, Insulin, Delivery framework, Growth hormones, Food and Nutraceuticals, All kinds of Surgical types of gear and Life-Saving medications.

Taj Pharma likewise drives accentuation to a wide range of nation drugs like-Ayurvedic, Herbal Products, and so on. Here you will discover finish answer for customary wellbeing and individual consideration, body care, and healthy skin prerequisites. Taj Pharmaceuticals Ltd key center regions for development incorporate real Therapeutic Segments like Cardiovascular, CNS, Cancer, Aids, incendiary and Ophthalmology. Having characterized a marked items portfolio, Taj Pharma is currently searching for Marketing Firms/Distributors/Agents with complimentary aptitudes, People who can expand the compass of our brands and/or for whom we can broaden the scope of their brands.

Taj Pharma products can broadly be categorized into four main ranges

· Pharmaceutical

· Personal Care

· Well-being

· Animal Health

What makes Taj Pharma reviews exceptional is the quality that has been dependably a solid piece of Taj Pharmaceuticals recommendation. Care is taken to guarantee an abnormal state of value in items and administrations.

About Taj Pharmaceuticals

Founded in 1985 by our Chairman of board of director Dr.Ranveer Kumar Singh, Taj Pharmaceuticals is one of the fastest growing pharmaceutical development and manufacturing companies in India.

Outstanding customer service and the highest manufacturing standards have driven our success. Taj Pharma is consistently ranked as the top performer in Indian Pharma Expo & Business Excellence Awards 2018 surveys on pharmacist satisfaction.

Taj Pharmaceuticals is currently enjoying significant growth as it expands to meet international demand. Taj Pharma has considerable investment in product development laboratories, a specially-designed containment suite for manufacture of potent products and the provision of fully compliant registration dossiers in CTD (Common Technical Dossier) format are examples of our commitment to both the domestic and global market.

Taj Pharmaceuticals Limited — Russia and CIS

Fact Facts

Company name: Taj Pharmaceuticals Limited

Company address: Mumbai India

Date established: 1985

Chairman: Dr. Ranveer Kumar Singh

Managing Director: Abhishek Kumar Singh

Chief Financial Officer: Shantanu Kumar Singh

Number of employees: 450

Product expertise:

• High potency/containment manufacturing of tables, capsules, hard gelatin capsules, semisolids (e.g. retinoids, anticancer, immunosuppressants, steroids)
• API (Active Pharmaceutical Ingredient) products (e.g. pimozide)
• Novel formulations (trientine capsules)
• New strengths for existing products

Product Presentation Strength Condition: Acitretin capsule 10mg, 17.5mg, 22.5mg Psoriasis Anastrozole tablets 1mg Breast Cancer Azathioprine film coated tablets 25 mg, 50 mg, 75 mg, 100 mg Immunosuppressant Bicalutamide filmcoated tablets 50mg Prostrate Cancer Clozapine tablets 25 mg, 50 mg, 100 mg, 200 mg Schizophrenia Clozapine suspension 50mg/ml Schizophenia Cyproterone acetate tablets 50mg, 100mg Prostate Cancer Dutasteride softgel capsules 0.5mg Benign Prostatic Hypertrophy Ethinylestradiol/cyproterone acetate tablets 35mcg/2mg Exemestance tablets 25mg Breast Cancer Isotretinoin softgel capsules 5mg, 10mg, 20mg, 30mg, 40mg Severe Acne Letrozole tablets 2.5mg Breast Cancer Paricalcitol softgel capsules 1,2mcg Hyperparathyroidism Quetiapine tablets 25mg, 100mg, 200mg, 300mg Schizophrenia Risperidone tablets 0.5mg, 1mg, 2mg, 3mg, 4mg, 6mg Schizophrenia Rivastigmine capsules 1.5mg, 3mg, 4.5mg, 6mg Alzheimers Disease

* Licensing Conditions Apply as per end countries

History snapshot

• Founded in 1985, Taj Pharmaceuticals was initially a marketer and distributor of ethical and over-the-counter (OTC) medicines in Mumbai, India. In the 2000s the company began manufacturing generic pharmaceuticals for the local market.
• In the 2005s, as a consequence of Indian health sector reforms, Taj Pharma increased its focus on export activities. This move resulted in the restructuring of core operations into two distinct business activities: domestic in-licensing and agency operations, to supply the Indian retail pharmacy sector own and in-licensed generics, OTC’s and nutraceutical/dietary supplements; and export out-licensing operations, to supply generic medicines and dietary supplements to global markets.
• Taj Pharmaceuticals’ domestic operation has grown to more than $57 million annually and today employs one of the largest field sales teams in India. The sales team services retail pharmacy, health stores, hospitals, doctors and specialists.
• Currently we are supplying close to 450 unique generic products to more than 60 customers in 35 countries around the world.

Quality & Compliance

Taj Pharmaceuticals is committed to 100% compliance with internationally recognised quality systems and good manufacturing practices. Our customers have the highest degree of assurance that our products are manufactured and controlled to the levels required by the world’s most demanding health authorities.

Quality and compliance proof points:

• Our manufacturing operations are conducted in accordance with the current requirements of the internationally recognised ‘PIC/S (Pharmaceutical Inspection Cooperation Scheme) Guide to Good Manufacturing Practice for Medicinal Products’.
• All facilities, systems and procedures are regularly inspected by the Indian Ministry of Health and Local State FDA’s Compliance. Consequently, we have a manufacturing licence and GMP (Good Manufacturing Practice) certificate issued by Indian Food and Drug Departments in compliance with WHO | GMP guidelines.
• We are also licensed by Indian Central Drug Authority to manufacture veterinary medicines.
• We are a registered pharmaceutical manufacturer with the Russian and Australian Therapeutic Goods Administration (TGA).

Our quality control and quality assurance systems have been successfully inspected by the USA FDA (United States Food and Drug Administration).

Research & Development

Research and development at Taj Pharmaceuticals is driven by the specific needs of our domestic and international customers. Our discovery programme is focused primarily on preparing brand-name equivalent drugs and the development of ANDA and NCEs (New Chemical Entities).

Taj Pharmaceuticals New Drug Development and F&D Department occupies a state-of-the-art laboratory complex at Taj Pharma Sanand. This facility includes three pilot scale manufacturing plants (two fully dedicated to the manufacture of high potency products); two instrument rooms (one with controlled lighting for the analysis of light-sensitive compounds); and an office suite for Chemistry, Manufacturing and Controls documentation writing and data validation.

Programme capabilities:

• We have expertise in the development and manufacture of specialised high potency tablets, hard-gelatin capsules and pre-filled syringe products.
• We have developed and produced alternative-branded generics for global markets, fully supported by patient programmes and promotional material.
• Our team provides CMC services to both generic and NCE clients in compliance with EMA (European Medicines Agency), US FDA (United States Food and Drug Administration) and ICH (International Committee on Harmonisation) guidelines.
• Many of the generic products we develop are poorly soluble and can present considerable challenges to the achievement of BE (Bioequivalence). Overcoming solubility challenges is a strength of ours.
• We can assist with formulation and CMC needs for IND-ANDA (Abbreviated New Drug Application) filings.

High quality pharmaceutical manufacturing

Taj Manufacturing was established in 1985, when Taj Pharmaceuticals expanded its operation beyond distribution and marketing.

Our manufacturing capabilities and laboratory services are valued by an increasing portfolio of international and multi-national clients. In particular, we manufacture and export an extensive product range for customers in Russian, Australasia, Europe, Asia, America and the Middle East. Focus is firmly on high standards and client satisfaction.

On the world stage, rigorous attention to product quality, WHO — GMP (Good Manufacturing Practice) compliance and patient safety are key points of difference for Taj Pharma Manufacturing.

Taj Manufacturing is WHO-GMP and FDA approved gaining its most recent approval in July 2016.

Regulatory Affairs

To ensure products enter their intended markets without problems, we have regulatory affairs teams specialised in the requirements for Russia, Australia, Africa, South Africa, Asia, Europe, the Middle East and North, Central and South America. The teams work closely together, which gives us the benefit of global thinking combined with local knowledge.

The primary focus for our regulatory affairs personnel is the preparation and maintenance of product registration dossiers. To support product registrations, we also arrange application for and maintenance of the company’s trademarks. Taj Pharmaceuticals currently owns a portfolio of more than 450 trademarks in global markets.

Export partners can confidently trust our management of regulatory affairs because we apply the International Committee on Harmonisation (ICH) and Asean guidelines for pharmaceutical development.

Taj Pharma products and/or developments are currently registered or awaiting registration in the following countries: Russia, Argentina, Australia, Austria, Bangladesh, Belgium, Botswana, Cambodia, Canada, Chile, Czech Republic, Colombia, Denmark, El Salvador, Estonia, Finland, France, GCC, Germany, Greece, Hong Kong, Hungary, Indonesia, Iran, Ireland, Israel, Italy, Korea, Latvia, Lithuania, Luxembourg, Malaysia, Malta, Mexico, Netherlands, New Zealand, Norway, Pakistan, Philippines, Portugal, Romania, Singapore, Slovakia, Slovenia, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Taiwan, Thailand, Turkey, UAE, United Kingdom, Uruguay, USA, Venezuela and Vietnam

Work for us

Whether you’re an experienced pharmaceutical professional or just launching your career, working for Taj Pharmaceuticals is a pathway you should strongly consider.

We offer you a fast-moving, stimulating, quality-driven environment that provides unparalleled opportunities for career progression.

Outstanding customer service is the key to the success of Taj Pharmaceuticals. We are consistently ranked as the top-performing company by retail pharmacy. Our diverse and substantial client base will bring you face-to-face with some of India’s most innovative organisations and people.

Throughout your career, you will be challenged by the work and by the people on your team, as well as by the clients we serve. You will be constantly learning and your ideas will be welcomed in an atmosphere of collaboration and teamwork.

We provide learning and career development opportunities aimed at building your technical competence, self-development, team work abilities and leadership skills.

Find out about becoming part of an organization that values its people and is committed to quality healthcare.

Company Overview of Taj Pharmaceuticals Limited

Taj Pharmaceuticals Limited manufactures and distributes medicines. The company’s products include prescription solutions, lifesaving drugs, anti-cancer drugs, veterinary products, consumer brands, and CNS drugs. It focuses on medicines of anemia, anxiety disorders, cancer/oncology, ear infections, heart failure, hepatitis, HIV/AIDS, influenza, non-Hodgkin’s lymphoma, obesity, osteoporosis, Parkinson’s disease, pneumonia, transplantation, and common diseases. Taj Pharmaceuticals Limited was founded in 2004 and is headquartered in Mumbai, India.

Taj Pharmaceuticals, Taj Pharmaceutical Company, Taj Pharmaceuticals, Taj Pharmaceuticals India, Taj Pharmaceuticals Limited, Priyanka Singh Taj Pharma, Abhishek Singh Taj Pharma, Taj Pharmaceuticals Mumbai, Abhishek Kumar Singh Taj Pharma, Priyanka Singh Director Taj Pharma Group, Dr Ranvir Singh Taj Pharma, Dr.Ranvir Singh chairman Taj Pharmaceuticals, Shantanu Singh Director Taj Pharmaceuticals, Abhishek Singh Taj Pharma Mumbai, Priyanka Singh Taj Pharma, Taj Generics Medicines, India’s fastest rising women, Director Taj Pharma, Starting up Priyanka Singh, Taj Pharmaceuticals Bombay, Taj Pharmaceuticals products, Priyanka Singh Taj, Priyanka Singh Taj Agro, Priyanka Singh Director Taj Pharma, Directors of Taj Pharma, Taj Pharmaceuticals News, Taj Pharma News Special Reports, Mumbai-based Taj Pharmaceuticals Limited, Taj Pharma, Taj Pharmaceuticals Limited, Taj Pharma Mumbai, Taj Pharmaceuticals Mumbai, Taj Pharma News Reports, Mumbai-based Taj Pharmaceuticals, Promoters of Taj Pharmaceuticals Limited, Taj Pharmaceuticals Directors, taj pharmaceuticals ceo

• Shantanu Singh Taj Pharma
• Shantanu Taj Pharma India
• Shantanu Singh Cfo Taj
• Taj Pharma News
• Taj Pharma Cfo

100 claps

Applause from Taj Pharma and 1 other